Provided by Tiger Trade Technology Pte. Ltd.

Recursion Pharmaceuticals, Inc.

3.33
-0.0660-1.94%
Volume:1.35M
Turnover:4.48M
Market Cap:1.78B
PE:-3.26
High:3.35
Open:3.35
Low:3.28
Close:3.40
52wk High:7.18
52wk Low:2.77
Shares:535.00M
Float Shares:522.33M
Volume Ratio:1.55
T/O Rate:0.26%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-1.0219
EPS(LYR):-1.4410
ROE:-56.58%
ROA:-27.33%
PB:1.95
PE(LYR):-2.31

Loading ...

Aug 08, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 08, 2024

Quarterly Report

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Aug 08, 2024

Major Issues Report

Form 8-K - Current report
Aug 07, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Aug 06, 2024

Major Issues Report

Form 8-K - Current report
Jul 25, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 23, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 11, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 10, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 09, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jul 08, 2024

Beneficial Ownership Change

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Jun 27, 2024

Proposed Sale Of Securities

Form144 | Recursion Pharmaceuticals' Officer Tina Marriott proposes to sell 6000 Shares, with a total value of approximately $43290.
Jun 27, 2024

Major Issues Report

Form 8-K - Current report
Jun 25, 2024

Proposed Sale Of Securities

Form144|Recursion Pharmaceuticals' Director Blake Borgeson proposes to sell 11447 Shares, with a total value of approximately $1.09 Million.
Jun 24, 2024

Major Issues Report

Form 8-K - Current report
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities
Jun 14, 2024

Proposed Sale Of Securities

Form 144 - Report of proposed sale of securities